article_metadata: Yohei Takahashi Takeshi Kezuka Keigo Shikishima Akiko Yamagami Hideki Chuman Makoto Nakamura Satoshi Ueki Akiko Kimura Masato Hashimoto Sonoko Tatsui Kimiyo Mashimo Hitoshi Ishikawa
article_metadata: 10.1007/s10384-024-01129-4
article_metadata: Jpn J Ophthalmol
article_metadata: 2025 Jan;69(1):81-92.
article_metadata: biologics neuromyelitis optica spectrum disorders optic neuritis oral steroid satralizumab
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/39470886/
article_metadata: Neuromyelitis Optica / diagnosis Neuromyelitis Optica / drug therapy Optic Neuritis / diagnosis Optic Neuritis / drug therapy
article_metadata: Neuromyelitis Optica / diagnosis Neuromyelitis Optica / drug therapy Optic Neuritis / diagnosis Optic Neuritis / drug therapy Multicenter Study Adult Aged Aquaporin 4 / immunology Biological Products / administration & dosage Biological Products / adverse effects Female Follow-Up Studies Humans Japan / epidemiology Male Middle Aged Retrospective Studies Treatment Outcome Visual Acuity Aquaporin 4 Biological Products
article_metadata: PMC11821680
article_metadata: 39470886
article_metadata: Usage status of biologics for the chronic treatment of optic neuritis in neuromyelitis optica spectrum disorders in Japan
article_metadata: 2025